Daily temporal dynamics of vaginal microbiota before, during and after episodes of bacterial vaginosis

BackgroundBacterial vaginosis (BV) is a common gynecologic diagnosis characterized by dysbiosis of the vaginal microbiota. It is often accompanied by vaginal symptoms such as odor and discharge, but can be asymptomatic. Despite over 50 years of research, the etiology of BV is not well understood, which is a major impediment to treatment and prevention of BV.ResultsHere we report on the temporal dynamics of 25 vaginal communities over a 10 week period using samples collected daily from women who were diagnosed with symptomatic BV (15 women), asymptomatic BV (6 women), and women who did not have BV (4 women).ConclusionThis unique resource of samples and data will contribute to a better understanding of the role that the vaginal microbes have in the natural history of BV and lead to improved diagnosis and treatment.

[1]  Jun Zhang,et al.  Vulvovaginal Symptoms in Women With Bacterial Vaginosis , 2004, Obstetrics and gynecology.

[2]  C. Beck-Sague,et al.  Behaviors Associated with Neisseria gonorrhoeae and Chiamydia trachomatis: Cervical Infection Among Young Womena Attending Adolescent Clinics , 2000, Clinical pediatrics.

[3]  Jeanne M. Marrazzo,et al.  Bacterial Communities in Women with Bacterial Vaginosis: High Resolution Phylogenetic Analyses Reveal Relationships of Microbiota to Clinical Criteria , 2012, PloS one.

[4]  J. Marrazzo,et al.  Molecular identification of bacteria associated with bacterial vaginosis. , 2005, The New England journal of medicine.

[5]  D. Taylor-Robinson,et al.  Comparison of Gram‐stained smears prepared from blind vaginal swabs with those obtained at speculum examination for the assessment of vaginal flora , 1996, British journal of obstetrics and gynaecology.

[6]  David H. Martin,et al.  The Microbiota of the Vagina and Its Influence on Women's Health and Disease , 2012, The American journal of the medical sciences.

[7]  R. Ness,et al.  A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease. , 2005, American journal of epidemiology.

[8]  K. Holmes,et al.  Nonspecific vaginitis: Diagnostic criteria and microbial and epidemiologic associations , 1983 .

[9]  J. Marrazzo,et al.  Temporal Variability of Human Vaginal Bacteria and Relationship with Bacterial Vaginosis , 2010, PloS one.

[10]  L. Meyn,et al.  Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  K. Workowski,et al.  Centers for Disease Control and Prevention Sexually Transmitted Disease Treatment Guidelines. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  M. Krohn,et al.  Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  K. Holmes,et al.  Diagnosis of bacterial vaginosis by direct gram stain of vaginal fluid , 1983, Journal of clinical microbiology.

[14]  K. Workowski,et al.  Sexually transmitted diseases treatment guidelines, 2006. , 2006, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[15]  S. Hillier,et al.  Reproducibility of a scoring system for gram stain diagnosis of bacterial vaginosis , 1991, Journal of clinical microbiology.

[16]  Stuart Berman,et al.  Sexually transmitted diseases treatment guidelines, 2010. , 2010, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[17]  P. Nyirjesy,et al.  Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. , 2006, American journal of obstetrics and gynecology.

[18]  G. Burstein,et al.  Sexually transmitted diseases treatment guidelines , 2003, Current opinion in pediatrics.

[19]  G. Olsen,et al.  Critical Evaluation of Two Primers Commonly Used for Amplification of Bacterial 16S rRNA Genes , 2008, Applied and Environmental Microbiology.

[20]  William A. Walters,et al.  Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms , 2012, The ISME Journal.

[21]  J. Kendrick,et al.  The Prevalence of Bacterial Vaginosis in the United States, 2001–2004; Associations With Symptoms, Sexual Behaviors, and Reproductive Health , 2007, Sexually transmitted diseases.

[22]  D. Scharfstein,et al.  The effect of vaginal douching cessation on bacterial vaginosis: a pilot study. , 2008, American journal of obstetrics and gynecology.

[23]  J. Schwebke,et al.  The Use of Sequential Self‐Obtained Vaginal Smears for Detecting Changes in the Vaginal Flora , 1997, Sexually transmitted diseases.

[24]  Jacques Ravel,et al.  Comparison of Self-Collected and Physician-Collected Vaginal Swabs for Microbiome Analysis , 2010, Journal of Clinical Microbiology.

[25]  C. Ison,et al.  Validation of a simplified grading of Gram stained vaginal smears for use in genitourinary medicine clinics , 2002, Sexually transmitted infections.

[26]  P. Gajer,et al.  Vaginal microbiome of reproductive-age women , 2010, Proceedings of the National Academy of Sciences.

[27]  M A Krohn,et al.  Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation , 1991, Journal of clinical microbiology.

[28]  B. Chohan,et al.  Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. , 1999, The Journal of infectious diseases.

[29]  J. Ravel,et al.  Evaluation of Methods for the Extraction and Purification of DNA from the Human Microbiome , 2012, PloS one.